Ernexa Therapeutics Inc.
13F holders, Q1 2025 (March 31)27holders +3
6new positions
3sold out
1famous investor
$0.18avg. 13F price*
At the end of Q1 2025, 27 institutions reported holding Ernexa Therapeutics Inc. in their 13F filings, up 3 from Q4 2024. 6 opened new positions and 3 sold out. The largest holders were Geode Capital Management, LLC ($52K), Corient Private Wealth LP ($47K) and Two Sigma Securities, LLC ($41K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Ernexa Therapeutics Inc.
- CUSIP
- 114082209
- Latest filing quarter
- Q1 2025
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 6 | $31K |
| Exits | 3 | $29K |
All 13F filers, Q4 2024 → Q1 2025: 615,372 shares bought and 121,378 shares sold, net +493,994 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 27 holders
| Geode Capital Management, LLC | 0.00% | Add +13.9% | 293,148 | $52K |
| Corient Private Wealth LP | 0.00% | No change | 262,862 | $47K |
| Two Sigma Securities, LLC | 0.01% | Add +671.3% | 229,338 | $41K |
| Citigroup Inc. | 0.00% | Add +1020933.3% | 153,155 | $27K |
| Cypress Point Wealth Management, LLC | 0.01% | No change | 94,375 | $17K |
| Sippican Capital Advisors | 0.01% | Add +60.0% | 80,000 | $14K |
| Vanguard Personalized Indexing Management, LLC | 0.00% | New | 67,623 | $12K |
| Citadel Advisors | 0.00% | New | 65,572 | $12K |
| Naviter Wealth, LLC | 0.00% | No change | 47,271 | $8K |
| XTX Topco Ltd | 0.00% | Reduce -28.8% | 41,382 | $7K |
| HRT Financial LP | 0.00% | New | 42,499 | $7K |
| Vanguard Group Inc. | 0.00% | Add +46.3% | 38,190 | $7K |
| Goldman Sachs Group Inc. | 0.00% | Add +40.9% | 18,050 | $3K |
| Avidian Wealth Enterprises, LLC | 0.00% | No change | 14,798 | $3K |
| UBS Group AG | 0.00% | Reduce -26.0% | 12,473 | $2K |
| BlackRock, Inc. | 0.00% | Reduce -17.6% | 12,300 | $2K |
| one8zero8, LLC | 0.00% | No change | 10,873 | $2K |
| Assetmark, Inc. | 0.00% | New | 2,000 | $356 |
| EverSource Wealth Advisors, LLC | 0.00% | New | 1,754 | $312 |
| Bank of America Corp. | 0.00% | Add +4.8% | 309 | $55 |
| Montag A & Associates Inc. | 0.00% | Reduce -33.5% | 141 | $26 |
| BNP Paribas Financial Markets | 0.00% | No change | 140 | $25 |
| JPMorgan Chase & Co. | 0.00% | Reduce -10.2% | 53 | $9 |
| Activest Wealth Management | 0.00% | No change | 50 | $9 |
| Group One Trading LLC | 0.00% | No change | 19 | $3 |
| SBI Securities Co., Ltd. | 0.00% | No change | 10 | $2 |
| FMR LLC | 0.00% | New | 2 | $0 |
"% of holder's portfolio" is ERNEXA THERAPEUTICS INC's weight in each manager's 13F, not the share of Ernexa Therapeutics Inc. the manager owns.